Literature DB >> 18183485

A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice.

Marina Simian1, Teresita Manzur, Vanina Rodriguez, Elisa Bal de Kier Joffé, Slobodanka Klein.   

Abstract

Currently, an in vivo spontaneous model of estrogen dependent, tamoxifen sensitive breast cancer does not exist. We show here the characterization of the M05 mammary tumor that appeared spontaneously in a 1-year-old virgin female BALB/c mouse in our animal facility. The M05 tumor is a semi-differentiated adenocarcinoma that expresses estrogen and progesterone receptors. When it was transplanted to either male or ovariectomized female mice it did not grow. Moreover, ovariectomy or treatment with tamoxifen of tumor bearing mice led to a halt in tumor growth. Treatment of ovariectomized mice that had been inoculated with the M05 tumor showed that only estradiol, but not progesterone, promoted the re-growth of the tumor. Finally, after passage nine, tumor growth was achieved in male and ovariectomized female mice suggesting that the tumor had progressed to hormone independence. However, like often found in the clinic, expression of estrogen and progesterone receptors was maintained. This model mimics the biology of estrogen receptor positive breast cancer in humans and presents itself as an invaluable tool for the study of endocrine resistance in a physiologically relevant setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18183485     DOI: 10.1007/s10549-007-9888-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  6 in total

1.  The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin.

Authors:  Osvaldo Pontiggia; Rocio Sampayo; Diego Raffo; Andrea Motter; Ren Xu; Mina J Bissell; Elisa Bal de Kier Joffé; Marina Simian
Journal:  Breast Cancer Res Treat       Date:  2011-09-21       Impact factor: 4.872

2.  Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.

Authors:  Maria Laura Polo; Maria Victoria Arnoni; Marina Riggio; Victoria Wargon; Claudia Lanari; Virginia Novaro
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

3.  Microenvironment and endocrine resistance in breast cancer: Friend or foe?

Authors:  Sol Recouvreux; Rocío Sampayo; María Inés Díaz Bessone; Marina Simian
Journal:  World J Clin Oncol       Date:  2015-12-10

4.  STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.

Authors:  Szeman Ruby Chan; William Vermi; Jingqin Luo; Laura Lucini; Charles Rickert; Amy M Fowler; Silvia Lonardi; Cora Arthur; Larry Jt Young; David E Levy; Michael J Welch; Robert D Cardiff; Robert D Schreiber
Journal:  Breast Cancer Res       Date:  2012-01-20       Impact factor: 6.466

5.  Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells through the Activation of the MAPK/ERK Pathway.

Authors:  Damián E Berardi; Diego Raffo; Laura B Todaro; Marina Simian
Journal:  Cancer Res Treat       Date:  2016-12-06       Impact factor: 4.679

6.  iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity.

Authors:  María Inés Diaz Bessone; Lorena Simón-Gracia; Pablo Scodeller; María de Los Angeles Ramirez; María Amparo Lago Huvelle; Galo J A A Soler-Illia; Marina Simian
Journal:  J Nanobiotechnology       Date:  2019-12-07       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.